Biotricity CEO, Waqaas Al-Siddiq, to Participate in Panel Discussion on the Evolution of Medical Devices at the American Medical Device Summit on October 19th

Rhea-AI Summary

Biotricity (NASDAQ:BTCY) announced that Waqaas Al-Siddiq, the Founder and CEO, will speak at the American Medical Device Summit on October 19, 2022, in Chicago. The panel discussion focuses on medical devices in at-home patient care and will take place from 4:20 p.m. to 4:55 p.m. CST. The summit will feature over 50 speakers and 200 attendees, providing insights into trends and innovations in medical devices. Biotricity aims to enhance chronic care management and remote monitoring solutions.

REDWOOD CITY, CA / ACCESSWIRE / October 13, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that Waqaas Al-Siddiq, Founder and CEO, is scheduled to participate in a panel discussion at the American Medical Device Summit on October 19, 2022 in Chicago, Illinois.

American Medical Device Summit:

Location: Westin Chicago Lombard, Chicago, Illinois
Format: Panel Discussion "The Evolving Role of Medical Devices in Delivering At-Home Patient Care"
Date: Wednesday, October 19^th at 4:20 p.m. - 4:55 p.m. CST

The American Medical Device Summit provides insights and strategies to enhance the professional development of executives involved in the design, product development, innovation, technology and quality/ regulatory aspects of medical devices. The event will bring together 40 sponsors, 50+ speakers and 200 attendees - VPs and Directors of Design, Product Development, Innovation, Quality and Regulatory, etc. - to explore current trends and case studies.

About Biotricity Inc.

Biotricity is reforming the healthcare market by bridging the gap in remote monitoring and chronic care management. Doctors and patients trust Biotricity's unparalleled standard for preventive & personal care, including diagnostic and post-diagnostic solutions for chronic conditions. The company develops comprehensive remote health monitoring solutions for the medical and consumer markets. To learn more, visit www.biotricity.com.

Investor Relations:

Investor Relations:
Biotricity Inc.
(800) 590-4155
investors@biotricity.com

KCSA Strategic Communications
Valter Pinto or Jack Perkins
(212) 896-1254
Investors@biotricity.com

Media Contacts:

Erica Fiorini, Russo Partners
(212) 845-4253
Erica.Fiorini@russopartnersllc.com

SOURCE: Biotricity, Inc.

View source version on accesswire.com:
https://www.accesswire.com/720330/Biotricity-CEO-Waqaas-Al-Siddiq-to-Participate-in-Panel-Discussion-on-the-Evolution-of-Medical-Devices-at-the-American-Medical-Device-Summit-on-October-19th

FAQ

What is Biotricity's role in the American Medical Device Summit?

Biotricity CEO Waqaas Al-Siddiq will participate in a panel discussion on the evolving role of medical devices in at-home patient care.

When is the American Medical Device Summit taking place?

The American Medical Device Summit is scheduled for October 19, 2022.

What time will the panel discussion featuring Waqaas Al-Siddiq start?

The panel discussion will occur from 4:20 p.m. to 4:55 p.m. CST.

How many speakers and attendees will be at the American Medical Device Summit?

The summit will feature over 50 speakers and approximately 200 attendees.

What is Biotricity's focus in the healthcare market?

Biotricity focuses on bridging the gap in remote monitoring and chronic care management.